Ovarian Cancer Trial, Recruiting (NCT07451483)

Ovarian Cancer Trial, Recruiting NCT07451483 Sponsor: Jules Bordet Institute Condition: Ovarian Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT07451483 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Ovarian Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults aged 18 or older who had a specific type of major abdominal surgery (called cytoreductive surgery, with or without a heated chemotherapy wash called HIPEC) for one of three conditions: a mucus-producing abdominal condition called PMP, colorectal cancer that has spread to the abdominal lining, or ovarian cancer that has spread to the abdominal lining, and whose surgery took place between 1 January 2010 and 31 December 2024.

Who may not be able to join:

People who had a hernia in the abdominal wall at the site where the surgical cut was planned before their surgery.
People who had this type of major abdominal surgery for a cancer type other than the three listed above (PMP, colorectal, or ovarian).
People whose medical records are incomplete in a way that makes it impossible to gather the necessary information.
People who were lost to follow-up care within one year after their surgery.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Gabriel Liberale, MD, Phd, Jules Bordet Institute

Phone: +32 477606766

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07451483

Sponsor: Jules Bordet Institute

Phase: Not Applicable

Status: Recruiting

Condition: Ovarian Cancer

Trial contact: +32 477606766

More information: https://clinicaltrials.gov/study/NCT07451483

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults aged 18 or older who had a specific type of major abdominal surgery (called cytoreductive surgery, with or without a heated chemotherapy wash called HIPEC) for one of three conditions: a mucus-producing abdominal condition called PMP, colorectal cancer that has spread to the abdominal lining, or ovarian cancer that has spread to the abdominal lining, and whose surgery took place between 1 January 2010 and 31 December 2024.

Who may not be able to join:

People who had a hernia in the abdominal wall at the site where the surgical cut was planned before their surgery.
People who had this type of major abdominal surgery for a cancer type other than the three listed above (PMP, colorectal, or ovarian).
People whose medical records are incomplete in a way that makes it impossible to gather the necessary information.
People who were lost to follow-up care within one year after their surgery.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Jules Bordet Institute

Registry

ClinicalTrials.gov

Start date

20 January 2026

Est. completion

28 February 2026

Where this trial is recruiting

🇧🇪 Belgium

Primary endpoints

Cumulative incidence of post-operative ventral hernias

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov